All In Biotech

Drug Trial Radar · NCT01774045

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

A Dose Escalation Phase I Study of PDC-1421 Capsule to Evaluate the Safety in Healthy Volunteers

Last checked: Nov 20, 2026Latest source record: Aug 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Nov 2012

Primary completion

Jul 2013

Study completion Jul 2013

Sponsor

Lead sponsor
BioLite, Inc.Industry
Sponsor type
Industry
First posted
Jan 23, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Other
Who can join
All sexes, from 20 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety of PDC-1421 Capsule in healthy subject, find the effective adequate dose for the next stage of the study, and accumulate information of possible mechanism of its anti-depressive effect.

Conditions

  • Major Depressive Disorder

Interventions

  • PDC-1421Drug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Dose Limiting Toxicity of Physical ExaminationTime frame: baseline to 72 hours
  2. Number of Dose Limiting Toxicity of ElectrocardiographTime frame: baseline to 72 hours
  3. Number of Dose Limiting Toxicity of Vital SignTime frame: baseline to 72 hours
  4. Number of Dose Limiting Toxicity of Laboratory ValuesTime frame: baseline to 72 hours
  5. Number of Dose Limiting Toxicity of Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: baseline to 72 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Taipei Veterans General Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.